OntoBrowse: A World of Knowledge

This paper describes the creation and function of OntoBrowse, a domain-independent ontology browser system that was developed to provide generic access to any triplestore ontology without the need to create a bespoke interface. It features support for accessing multiple triplestores in one query session, bookmarks, Rendezvous sharing of bookmarks, multiple tabs, multiple windows, namespace caching and automatic generation of RDQL queries. OntoBrowse automatically loads images when referenced by URI and has a fully customisable user interface. In addition, the CIA World Factbook was asserted into a triplestore in order to gain a conceptual understanding of knowledge systems and for use as a controllable testing ground for the ontology browser

Representing disease courses: An application of the Neurological Disease Ontology to Multiple Sclerosis Typology

The Neurological Disease Ontology (ND) is being developed to provide a comprehensive framework for the representation of neurological diseases (Diehl et al., 2013). ND utilizes the model established by the Ontology for General Medical Science (OGMS) for the representation of entities in medicine and disease (Scheuermann et al., 2009). The goal of ND is to include information for each disease concerning its molecular, genetic, and environmental origins, the processes involved in its etiology and realization, as well as its clinical presentation including signs and symptoms

Analysis of common oral and topical dermatologic medication price variation by source

Online coupon retailers and pharmacies are popular sites that patients can access discounted medications when compared to cash prices. These sources are especially important for those patients without insurance. In our study, we analyzed commonly prescribed topical and oral medications and compared the cash prices to the discounted medications based on a typical month of usage. We found savings in every one of the medications that we analyzed, some with savings up to hundreds of dollars. Savings were present in all the sources analyzed, with the coupon-based programs often having the lowest price. We suggest certain alternative prescribing guidelines when considering patients who may not be able to afford cash prices of medications. Our hopes with this study are to quantify savings for discounted medications as well as to help physicians target more affordable medications for their patients